132 Organizations Ask for Key Medicare Part D OOP Reforms in Budget Reconciliation Package

Jennifer Duplessie
September 9, 2021 Chairman Ron Wyden Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Chairman Frank Pallone House Committee on Energy and Commerce 2125 Rayburn House Office Building Washington, DC 20515 Chairman Richard Neal House Committee on Ways and Means 1102 Longworth House Office Building
Read More

RE: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model; CMS-1749-P

Jennifer Duplessie
August 31, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health & Human Services 7500 Security Boulevard Baltimore, MD 21244 RE:
Read More

AAKP Letter Re: Calcimimetics Drugs 8.12.21

Jennifer Duplessie
August 11, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue Southwest Washington, D.C. 20201 Dear Administrator Brooks-LaSure, As the oldest and largest kidney patient organization in the United States, the American Association of Kidney Patients (AAKP)
Read More

NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS

Jennifer Duplessie
NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS The American Association of Kidney Patients (AAKP), the nation’s largest patient organization representing kidney transplant patients and living organ donors, thanks the Centers for Disease Control and Prevention (CDC)
Read More

Letter to Senator Murray re Support of Vascular Graft Research

Jennifer Duplessie
The Honorable Patty MurrayDefense Appropriations SubcommitteeU.S. SenateWashington, D.C. 20510 Dear Senator Murray: On behalf of of a coalition of concerned Washington State-based stakeholders, I am writing to you to request your support of continued federal research for new synthetic vascular graft technology.
Read More